PAREXEL introduced its Perceptive Cloud

| By | Clinical Trials, Drug Development, Parexel

PAREXEL International Corporation, a leading global biopharmaceutical services organization, introduced the Perceptive® Cloud to the life sciences industry, as part of the organization’s recent alliance with Microsoft Corp.  

Perceptive Cloud elevates PAREXEL Informatics solutions into an enhanced cloud infrastructure built on Microsoft Azure, combining PAREXEL’s extensive industry expertise and innovative technology solutions with the power of Microsoft’s intelligent cloud services and investment in global compliance certifications and enterprise-grade security. The first group of integrated cloud services will include LIQUENT InSight® Regulatory Information Management (RIM), Study Start-Up, DataLabs® Electronic Data Capture (EDC), Managed Access Programs, and IMPACT ® Clinical Trial Management (CTMS).

“In drug development today, the time to treatment continues to grow longer. This is due, in large part, to the use of conventional, disparate systems that simply digitize manual processes,” said Paul Bidez, Vice President of Regulatory and Clinical Solutions for PAREXEL. “Perceptive Cloud represents an opportunity to automate and streamline workflows and provide greater access to high quality data, simplifying the drug development journey with the objective of ultimately bringing new therapies to patients sooner.”

Perceptive Cloud is designed to respond to the need within healthcare to deliver cost-effective innovation while trusting that sensitive information will stay secure across global environments. Introducing Perceptive Cloud represents the first milestone of the enterprise alliance between PAREXEL and Microsoft aimed at leveraging the cloud to optimize performance and jointly innovate to offer new clinical development solutions and more site- and patient-centric technologies.

“Most life sciences solutions to date have been developed with the end result in mind, not the user experience, creating bottlenecks and inefficiencies across the drug development chain,” said Paul Slater, Worldwide Industry Strategist, Pharmaceuticals, Microsoft Health. “Both Microsoft and PAREXEL are committed to developing technologies that better engage patients, sites and sponsors to optimize clinical and operational effectiveness and digitally transform health. The Perceptive Cloud is only the first step in this effort.”

SOURCE: parexel
GMP news
Pharmaceutical industry News and events. Technology transfer and contract manufacturing of medicines.